Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
45.78
-0.29 (-0.63%)
At close: Mar 13, 2026, 4:00 PM EDT
45.06
-0.72 (-1.57%)
After-hours: Mar 13, 2026, 5:36 PM EDT
KNSA Employees
Kiniksa Pharmaceuticals International, had 366 employees as of December 31, 2025. The number of employees increased by 51 or 16.19% compared to the previous year.
Employees
366
Change (1Y)
51
Growth (1Y)
16.19%
Revenue / Employee
$1,851,268
Profits / Employee
$161,216
Market Cap
3.50B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 366 | 51 | 16.19% | 366 | 0 |
| Dec 31, 2024 | 315 | 18 | 6.06% | 315 | 0 |
| Dec 31, 2023 | 297 | 77 | 35.00% | 297 | 0 |
| Dec 31, 2022 | 220 | 5 | 2.33% | 220 | 0 |
| Dec 31, 2021 | 215 | 47 | 27.98% | 215 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,780 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 778 |
KNSA News
- 17 days ago - Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 19 days ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 23 days ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 7 weeks ago - Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator - Seeking Alpha
- 2 months ago - Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Kiniksa Pharmaceuticals Provides Corporate Update - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire